Young-Woo Sohn - Related publications

Psychology Yonsei University, Seoul, South Korea 
Memory, Skill Acquisition, HCI
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Park DG, Kim JW, An YS, Chang J, Yoon JH. Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 34568970 DOI: 10.1007/s00702-021-02423-y   
2021 Ravi DK, Baumann CR, Bernasconi E, Gwerder M, Ignasiak NK, Uhl M, Stieglitz L, Taylor WR, Singh NB. Does Subthalamic Deep Brain Stimulation Impact Asymmetry and Dyscoordination of Gait in Parkinson's Disease? Neurorehabilitation and Neural Repair. 15459683211041309. PMID 34551639 DOI: 10.1177/15459683211041309   
2021 Saleh C, Meyer A, Chaturvedi M, Beltrani S, Gschwandtner U, Fuhr P. Does Quantitative Electroencephalography Refine Preoperative Cognitive Assessment in Parkinson's Disease Patients Treated with Deep Brain Stimulation? A Follow-Up Study. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 34569496 DOI: 10.1159/000519053   
2021 Shieh KR, Huang A, Xu Y. Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study. Frontiers in Medicine. 8: 669587. PMID 34458284 DOI: 10.3389/fmed.2021.669587   
2021 Ma KS, Hasturk H, Carreras I, Dedeoglu A, Veeravalli JJ, Huang JY, Kantarci A, Wei JC. Dementia and the Risk of Periodontitis: A Population-Based Cohort Study. Journal of Dental Research. 220345211037220. PMID 34643147 DOI: 10.1177/00220345211037220   
2021 Poonja S, Miyasaki J, Fu X, Camicioli R, Sang T, Yuan Y, Ba F. The Trajectory of Motor Deterioration to Death in Parkinson's Disease. Frontiers in Neurology. 12: 670567. PMID 34484095 DOI: 10.3389/fneur.2021.670567   
2021 Brendel M, Su C, Hou Y, Henchcliffe C, Wang F. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data. Npj Parkinson's Disease. 7: 83. PMID 34535682 DOI: 10.1038/s41531-021-00228-0   
2021 Li R, Jose A, Poon J, Zou C, Istafanos M, Yao SC. Efficacy of osteopathic manipulative treatment in patients with Parkinson's disease: a narrative review. Journal of Osteopathic Medicine. PMID 34547197 DOI: 10.1515/jom-2021-0081   
2021 Xu ZN, Huang JJ, Zhou J, Huang WS, Guo YJ, Cai MY, Zhou JW, Lin LT, Liang LC, Zhu KS. [Efficacy and safety of anti-PD-1 monoclonal antibody in advanced hepatocellular carcinoma after TACE combined with TKI therapy]. Zhonghua Nei Ke Za Zhi. 60: 630-636. PMID 34619840 DOI: 10.3760/cma.j.cn112138-20200928-00841   
2021 Park S, Kim A, Park G, Kwon O, Park S, Yoo H, Jang J. Investigation of Therapeutic Response Markers for Acupuncture in Parkinson's Disease: An Exploratory Pilot Study. Diagnostics (Basel, Switzerland). 11. PMID 34574038 DOI: 10.3390/diagnostics11091697   
2021 Salari M, Etemadifar M, Zali A, Aminzade Z, Navalpotro-Gomez I, Tehrani Fateh S. Covid-19 in Parkinson's Disease treated by drugs or brain stimulation. Neurologia (Barcelona, Spain). PMID 34511276 DOI: 10.1016/j.nrl.2021.07.002   
2021 Salari M, Etemadifar M, Zali A, Aminzade Z, Navalpotro-Gomez I, Fateh ST. Neurologia (Barcelona, Spain). PMID 34366530 DOI: 10.1016/j.nrl.2021.07.002   
2021 van Zeijl MCT, van den Eertwegh AJM, Wouters MWJM, de Wreede LC, Aarts MJB, van den Berkmortel FWPJ, de Groot JB, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, van der Veldt AAM, Vreugdenhil G, et al. Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice. International Journal of Cancer. PMID 34520567 DOI: 10.1002/ijc.33800   
2021 Lien CY, Lu CH, Chang CC, Chang WN. Correlation between Hypovitaminosis D and Nutritional Status with The Severity of Clinical Symptoms And Impaired Cognitive Function in Patients with Parkinson's Disease. Acta Neurologica Taiwanica. 30: 63-73. PMID 34549391   
2021 Santos García D, Blázquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, García Ruiz PJ, Grandas F, Kulisevsky J, López-Manzanares L, Martínez Castrillo JC, Mir P, Pagonabarraga J, Pérez-Errazquin F, Salom JM, Tijero B, et al. Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences. 11. PMID 34439646 DOI: 10.3390/brainsci11081027   
2021 Zheng W, Xue Q, Sha X, Wang Y, Wang Y, Liu J, Zhang Y, Shi W. Successful PD-1 inhibitor treatment in a patient with refractory transformed follicular lymphoma who failed to respond to CAR-T cell therapy: a case report and literature review. Cancer Biology & Therapy. 1-7. PMID 34570671 DOI: 10.1080/15384047.2021.1967083   
2021 Yang Y, Yuan J, Liu L, Qie S, Yang L, Yan Z. Platelet-to-albumin ratio: a risk factor associated with technique failure and mortality in peritoneal dialysis patients. Renal Failure. 43: 1359-1367. PMID 34592885 DOI: 10.1080/0886022X.2021.1977319   
2021 Holanda VM, Eisinger RS, Almeida L, Tsuboi T, Wang H, Okun MS, Deeb W, Patterson A, Wagle Shukla A, Lobo Lopes J, Foote KD. Evolution of Globus Pallidus Targeting for Parkinson's and Dystonia Deep Brain Stimulation: A 15-Year Experience. Frontiers in Neurology. 12: 679918. PMID 34456844 DOI: 10.3389/fneur.2021.679918   
2021 Chao JY, Xiong KP, Zhuang S, Zhang JR, Huang JY, Li J, Mao CJ, Wu HH, Wang JY, Liu CF. [Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson's disease]. Zhonghua Yi Xue Za Zhi. 101: 2792-2797. PMID 34551496 DOI: 10.3760/cma.j.cn112137-20210130-00286   
2021 Zhong M, Gu R, Zhu S, Bai Y, Wu Z, Jiang X, Shen B, Zhu J, Pan Y, Yan J, Zhang L. Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease. Behavioural Neurology. 2021: 3469706. PMID 34646400 DOI: 10.1155/2021/3469706   
2021 Herrera AF, Burton C, Radford J, Miall F, Townsend W, Santoro A, Zinzani PL, Lewis D, Fowst C, Brar S, Huang B, Thall A, Collins GP. Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial. Blood Advances. 5: 3387-3396. PMID 34477818 DOI: 10.1182/bloodadvances.2021004511   
2021 Ismail SR, Lee SWH, Merom D, Megat Kamaruddin PSN, Chong MS, Ong T, Lai NM. Evidence of disease severity, cognitive and physical outcomes of dance interventions for persons with Parkinson's Disease: a systematic review and meta-analysis. Bmc Geriatrics. 21: 503. PMID 34551722 DOI: 10.1186/s12877-021-02446-w   
2021 Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson's disease (Review). Experimental and Therapeutic Medicine. 22: 1083. PMID 34447476 DOI: 10.3892/etm.2021.10517   
2021 Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein SM, Rottman JB, Naik GS, Sirard CA, Kagey MH, Chaney MF, Strickler JH. Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers. Molecular Cancer Therapeutics. PMID 34482288 DOI: 10.1158/1535-7163.MCT-21-0273   
2021 Domènech M, Muñoz Marmol AM, Mate JL, Estival A, Moran T, Cucurull M, Saigi M, Hernandez A, Sanz C, Hernandez-Gallego A, Urbizu A, Martinez-Cardus A, Bernat A, Carcereny E. Correlation between PD-L1 expression and gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver. Oncotarget. 12: 1802-1810. PMID 34504652 DOI: 10.18632/oncotarget.28045   
2021 Luis-Martínez R, Di Marco R, Weis L, Cianci V, Pistonesi F, Baba A, Carecchio M, Biundo R, Tedesco C, Masiero S, Antonini A. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. Bmc Neurology. 21: 332. PMID 34461838 DOI: 10.1186/s12883-021-02364-9   
2021 Wilbraham D, Biglan KM, Svensson KA, Tsai M, Pugh M, Ardayfio P, Kielbasa W. Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson Disease. Clinical Pharmacology in Drug Development. PMID 34664427 DOI: 10.1002/cpdd.1039   
2021 Zhu X, Liu L, Xiao Y, Li F, Huang Y, Han D, Yang C, Pan S. Abnormal Topological Network in Parkinson's Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging Study. Frontiers in Neuroscience. 15: 651710. PMID 34497483 DOI: 10.3389/fnins.2021.651710   
2021 de Havenon A, Castonguay A, Nogueira R, Nguyen TN, English J, Satti SR, Veznedaroglu E, Saver JL, Mocco J, Khatri P, Mistry E, Zaidat OO. Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke. Neurology. PMID 34544817 DOI: 10.1212/WNL.0000000000012827   
2021 Xu L, Liu L, Yao D, Zeng X, Zhang Y, Lai J, Zhong J, Zha X, Zheng R, Lu Y, Li M, Jin Z, Hebbar Subramanyam S, Chen S, Huang X, et al. PD-1 and TIGIT Are Highly Co-Expressed on CD8 T Cells in AML Patient Bone Marrow. Frontiers in Oncology. 11: 686156. PMID 34490086 DOI: 10.3389/fonc.2021.686156   
2021 He W, Wang JC, Tsai PY. Theta Burst Magnetic Stimulation Improves Parkinson's-Related Cognitive Impairment: A Randomised Controlled Study. Neurorehabilitation and Neural Repair. 1545968321104131. PMID 34467796 DOI: 10.1177/1545968321104131   
2021 Chung SJ, Cho KH, Lee YH, Yoo HS, Baik K, Jung JH, Ye BS, Sohn YH, Cha J, Lee PH. Diffusion tensor imaging-based pontine damage as a degeneration marker in synucleinopathy. Journal of Neuroscience Research. PMID 34521154 DOI: 10.1002/jnr.24926   
2021 Liu S, Yuan H, Liu J, Lin H, Yang C, Cai X. Comprehensive analysis of resting tremor based on acceleration signals of patients with Parkinson's disease. Technology and Health Care : Official Journal of the European Society For Engineering and Medicine. PMID 34657861 DOI: 10.3233/THC-213205   
2021 Navarro-Fernandez I, Gonzalez-Vela C, Gomez-Fernandez C, Duran-Vian C, Reguero L, Gonzalez-Lopez M. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma. Acta Dermatovenerologica Croatica : Adc. 291: 54-55. PMID 34477066   
2021 Schoenfeld AJ, Antonia SJ, Awad MM, Felip E, Gainor J, Gettinger SN, Hodi FS, Johnson ML, Leighl NB, Lovly CM, Mok T, Perol M, Reck M, Solomon B, Soria JC, et al. Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 34487855 DOI: 10.1016/j.annonc.2021.08.2151   
2021 Cui H, Li Y, Li S, Liu G. Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11: 693886. PMID 34490091 DOI: 10.3389/fonc.2021.693886   
2021 Lee SH, Lin CC, Wei CH, Chang KP, Yuan CT, Tsai CH, Liu JH, Hou HA, Tang JL, Chou WC, Tien HF. PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients. The Journal of Pathology. Clinical Research. PMID 34480529 DOI: 10.1002/cjp2.240   
2021 Vellata C, Belli S, Balsamo F, Giordano A, Colombo R, Maggioni G. Effectiveness of Telerehabilitation on Motor Impairments, Non-motor Symptoms and Compliance in Patients With Parkinson's Disease: A Systematic Review. Frontiers in Neurology. 12: 627999. PMID 34512495 DOI: 10.3389/fneur.2021.627999   
2021 Martignon C, Laginestra FG, Giuriato G, Pedrinolla A, Barbi C, Di Vico IA, Tinazzi M, Schena F, Venturelli M. Evidence That Neuromuscular Fatigue Is Not a Dogma in Patients with Parkinson's Disease. Medicine and Science in Sports and Exercise. PMID 34559731 DOI: 10.1249/MSS.0000000000002791   
2021 Zeng C, Yan C, Guo S, Zhu H, Chen Y, Zhan X. High-density lipoprotein cholesterol to apolipoprotein A1 ratio and all-cause mortality among incident peritoneal dialysis patients. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. PMID 34656383 DOI: 10.1016/j.numecd.2021.09.008   
2021 Rahman W, Lee S, Islam MS, Antony VN, Ratnu H, Ali MR, Mamun AA, Wagner E, Jensen-Roberts S, Waddell E, Myers T, Pawlik M, Soto J, Coffey M, Sarkar A, et al. Detecting Parkinson Disease Using a Web-Based Speech Task: Observational Study. Journal of Medical Internet Research. 23: e26305. PMID 34665148 DOI: 10.2196/26305   
2021 Rozas NS, Tribble GD, Jeter CB. Oral Factors That Impact the Oral Microbiota in Parkinson's Disease. Microorganisms. 9. PMID 34442695 DOI: 10.3390/microorganisms9081616   
2021 Kwon BS, Lee K, Kim ES, Jun SH, Lim SY, Song MJ, Kim YW, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Song J, Lee JH. A Prospective Cohort Study of Bioavailable 25-Hydroxyvitamin D Levels as a Marker of Vitamin D Status in Nontuberculous Mycobacterial Pulmonary Disease. Nutrients. 13. PMID 34444684 DOI: 10.3390/nu13082524   
2021 Clancy K, Hamill CS, O'Neill WQ, Vu B, Thuener J, Gui S, Li S, Fowler N, Rezaee R, Lavertu P, Wasman J, Patel M, Shaikh H, Vick E, Madabhushi A, et al. Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients. Cancers. 13. PMID 34638345 DOI: 10.3390/cancers13194861   
2021 Standaert DG, Aldred J, Anca-Herschkovitsch M, Bourgeois P, Cubo E, Davis TL, Iansek R, Kovács N, Pontieri FE, Siddiqui MS, Simu M, Bergmann L, Kukreja P, Robieson WZ, Chaudhuri KR. DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease. Movement Disorders Clinical Practice. 8: 1061-1074. PMID 34631942 DOI: 10.1002/mdc3.13239   
2021 Tan XS, Pierres F, Dallman-Porter A, Hardie-Brown W, Kwon KY. Focused Vibrotactile Stimulation With Cueing Effect on Freezing of Gait in Parkinson's Disease: Two Case Reports. Journal of Movement Disorders. PMID 34488302 DOI: 10.14802/jmd.21076   
2021 Zhao Z, Wang X, Qu J, Zuo W, Tang Y, Zhu H, Chen X. Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11: 708195. PMID 34604047 DOI: 10.3389/fonc.2021.708195   
2021 Miyawaki T, Naito T, Yabe M, Kodama H, Nishioka N, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Wakuda K, Ono A, Kenmotsu H, Murakami H, Mori K, Harada H, et al. Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 34550461 DOI: 10.1007/s00520-021-06572-4   
2021 Snyder A, Gruber-Baldini AL, Rainer von Coelln F, Savitt JM, Reich SG, Armstrong MJ, Shulman LM. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity. Journal of Parkinson's Disease. PMID 34366371 DOI: 10.3233/JPD-212705   
2021 Park JH, Kang SY. Dizziness in Parkinson's disease patients is associated with vestibular function. Scientific Reports. 11: 18976. PMID 34556776 DOI: 10.1038/s41598-021-98540-5